menu_book Explore the article's raw data

Antidiabetic and antioxidant studies of novel synthesized titanium (IV) complex: Design, synthesis, in-silico docking and in-vitro studies

Abstract

[{TiCl3}(2)(C3N3S3H)] (where C3N3S3H is Trithiocyanuric acid) was designed and synthesized by the reaction of TiCl4 and trithiocyanuric acid in 2:1 M ratio under stirring and refluxing condition using THF solvent. The synthesized Titanium (IV) complex was characterized by various spectroscopic techniques like FT-IR, NMR, MASS, XRD, UV-visible spectrophotometer and elemental analysis (CHNSO). Moreover, in-silico docking studies of the ligand and its Ti (IV) complex were carried out by AutoDockTools-1.5.6 to study interactions of the complex under study with the receptor protein. Afterwards, both ligand and synthesized Ti (IV)complex were screened for the antioxidant and antidiabetic potential by in-vitro method. The antioxidant potential was investigated by using DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assay where ligand exhibited moderate activity while Ti (IV) complex presented significant antioxidant activity. Following, alpha-amylase enzyme inhibition was investigated using iodine-starch inhibition assay. It was found that the ligand was inactive (showed no alpha-amylase inhibition activity) while the Ti (IV)complex was a potent alpha-amylase inhibitor. Furthermore, the experimentally obtained results were also complimented by the in-silico results.

article Article
date_range 2024
language English
link Link of the paper
format_quote
Sorry! There is no raw data available for this article.
Loading references...
Loading citations...
Featured Keywords

alpha-amylase inhibition
in-silico docking
myeloperoxidase
titanium (IV) complex
trithiocyanuric acid
Citations by Year

Share Your Research Data, Enhance Academic Impact